ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

CEFBRAN 200

Product Packing: 10X10

Product Composition: Cefixime 200 mg

Product Price: MRP : 1106.25

CEFBRAN 200 Tablets

Cefixime 200 mg Tablets

CEFBRAN 200 is a prescription antibacterial formulation containing Cefixime 200 mg. Cefixime is an oral third-generation cephalosporin antibiotic used for selected susceptible bacterial infections according to approved indications and clinical assessment.

Cefixime inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins, resulting in impaired cell-wall formation in susceptible bacteria. Antibiotic treatment should be based on an appropriate diagnosis and used according to the approved product label and qualified medical advice.

Composition

Each tablet contains:

·         Cefixime - 200 mg

·         Excipients - q.s.

 

Dosage form: Tablet

Pack size: 10 x 10 tablets

Uses of CEFBRAN 200

CEFBRAN 200 may be prescribed for selected bacterial infections caused by susceptible organisms where Cefixime therapy is approved and clinically appropriate.

·         Treatment of selected respiratory-tract bacterial infections according to approved prescribing information

·         Treatment of selected urinary-tract bacterial infections caused by susceptible organisms

·         Treatment of selected ear, throat or other approved bacterial infections where Cefixime is appropriate

·         Other approved susceptible bacterial infections as determined by the treating clinician

Cefixime does not treat viral infections such as the common cold or influenza. Unnecessary antibiotic use contributes to antimicrobial resistance.

How CEFBRAN 200 Works

CEFBRAN 200 contains Cefixime, a cephalosporin antibacterial medicine:

Cell-wall inhibition: Cefixime binds to bacterial penicillin-binding proteins and interferes with peptidoglycan synthesis.

Bactericidal action: Disruption of bacterial cell-wall formation can lead to death of susceptible bacteria.

Antibacterial spectrum: Activity depends on the bacterial species and local susceptibility or resistance patterns.

Clinical response depends on the infection site, organism susceptibility, dose, treatment duration and individual patient factors.

Dose selection and treatment duration must follow the approved product label and prescribing clinician's advice.

 

Dosage and Direction for Use

Use CEFBRAN 200 exactly as prescribed. Dose and duration depend on the infection, age, body weight, kidney function, clinical response and other patient factors.

Swallow the tablet with water at the time and frequency directed by the prescriber. Follow the approved label regarding administration with or without food.

Complete the prescribed course unless the treating healthcare professional advises otherwise. Do not skip doses or share antibiotics with others.

Dose adjustment may be required in significant renal impairment according to approved prescribing information.

Possible Side Effects

Possible unwanted effects may include:

·         Diarrhoea, nausea, abdominal discomfort or indigestion

·         Headache or dizziness in some individuals

·         Skin rash, itching or other hypersensitivity reactions can occur

·         Rare but serious reactions can include severe allergy, serious skin reactions, blood-cell abnormalities, liver effects or Clostridioides difficile-associated diarrhoea

·         Seek urgent medical attention for breathing difficulty, facial swelling, severe rash, persistent or bloody diarrhoea, jaundice or other serious symptoms.

Persistent or troublesome adverse effects should be discussed with the treating healthcare professional.

Precautions and Contraindications

Before using CEFBRAN 200, the prescriber should review allergy history, kidney function, gastrointestinal history and concomitant medicines. Important precautions include:

·         Do not use in patients with known hypersensitivity to Cefixime or other cephalosporins; patients with serious beta-lactam allergy require careful professional assessment.

·         Use caution in patients with significant renal impairment because dose adjustment may be necessary.

·         Antibiotic-associated diarrhoea, including C. difficile-associated disease, can occur during or after antibacterial treatment.

·         Prolonged or inappropriate use may promote overgrowth of non-susceptible organisms and antimicrobial resistance.

·         Patients taking anticoagulants or other medicines with clinically relevant interaction potential may require monitoring.

·         Pregnancy, breastfeeding, children, older adults and patients with significant chronic conditions require individualized professional guidance.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Cefixime can have clinically relevant interactions with certain medicines, including anticoagulants and some other drugs. Laboratory test interference may also occur with particular testing methods. Interaction significance depends on the individual patient and regimen.

·         Patients should provide the prescriber with a complete list of prescription medicines, OTC products and supplements before starting antibiotic therapy.

Business Growth Opportunity with CEFBRAN 200

CEFBRAN 200 offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Cefixime 200 mg prescription antibiotic tablet to their anti-infective product portfolio.

Antibacterial therapy is an established prescription healthcare segment. Promotion and use should support antimicrobial stewardship and remain strictly consistent with approved product information and applicable pharmaceutical regulations.

 

Key Business Advantages

·         Single-ingredient oral cephalosporin formulation

·         Cefixime 200 mg

·         Established third-generation cephalosporin antibiotic

·         Convenient tablet dosage form

·         Suitable addition to anti-infective and general prescription portfolios

·         Opportunity for ethical, stewardship-conscious promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for CEFBRAN 200

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for CEFBRAN 200 in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for CEFBRAN 200 and other quality-focused healthcare products.

Third-Party Manufacturing Support for Cefixime 200 mg Tablets

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to CEFBRAN 200 under their own brand, subject to applicable licensing, prescription-drug, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized product and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies and healthcare brands seeking to expand an anti-infective prescription product portfolio.

Frequently Asked Questions About CEFBRAN 200

1. What is CEFBRAN 200?

CEFBRAN 200 is a tablet formulation containing Cefixime 200 mg.

2. What is CEFBRAN 200 used for?

It may be prescribed for selected susceptible bacterial infections where Cefixime therapy is approved and clinically appropriate.

3. How should CEFBRAN 200 be taken?

Take CEFBRAN 200 exactly as prescribed by a qualified healthcare professional and complete the prescribed course unless advised otherwise.

4. Can CEFBRAN 200 be used for a common cold or flu?

No. Cefixime is an antibiotic for susceptible bacterial infections and does not treat viral infections such as the common cold or influenza.

5. Can Cefixime cause diarrhoea?

Yes. Diarrhoea can occur. Severe, persistent or bloody diarrhoea requires prompt medical assessment because antibiotic-associated colitis is possible.

6. Does kidney function affect Cefixime dosing?

Yes. Significant renal impairment may require dose adjustment according to approved prescribing information.

7. Is a PCD Pharma Franchise available for CEFBRAN 200?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Cefixime 200 mg tablet may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing and regulatory requirements.

Disclaimer

CEFBRAN 200 product information in this document is for general professional and business information. Exact approved indications, dosage, contraindications, warnings, interactions, susceptibility considerations, administration instructions, monitoring requirements, duration of use, excipients and regulatory status must be verified against the current approved product label and applicable prescribing information before prescribing, dispensing, use or promotion. Antibiotics should be used responsibly to support antimicrobial stewardship. This document is not a substitute for professional medical advice.

Contact